Antimicrobial resistance – time to start spending
(Source: Prescriber)
Source: Prescriber - December 31, 2016 Category: Primary Care Authors: Rob Munro Tags: Editorial Source Type: research

New from Nice
(Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Tags: New from Nice Source Type: research

Duavive HRT: conjugated oestrogens with bazedoxifene
This article discusses its properties, efficacy and adverse effects. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Steve Chaplin Tags: New Products Source Type: research

Religious constraints on prescribing medication
This article summarises the main dietary restrictions of the largest religious groups in the UK and the problems that may be encountered with medication ingredients. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Joy Ogden Tags: Analysis Source Type: research

NICE multimorbidity guideline: coping with complexity in care
This article provides a summary of the guidance and illustrates some of the issues raised with two clinical case studies. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Nina Barnett, Rupert Payne, Alaster Rutherford Tags: Guidelines Source Type: research

Recommended management of thyroid disorders
Most cases of primary hypothyroidism can be managed in general practice but thyrotoxicosis requires referral for an accurate diagnosis before treatment can be commenced. This review discusses the recommended management of thyroid disorders with a focus on autoimmune and iatrogenic hypothyroidism and Graves' disease. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Anthony Weetman Tags: Drug Review Source Type: research

SGLT2 inhibitors and risk of genitourinary infections
This article examines the extent of these risks and how they may affect treatment adherence. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Steve Chaplin Tags: Therapy Focus Source Type: research

Advances in the prevention and treatment of dementia
This article explores recent developments in the search for more effective interventions for the prevention and treatment of Alzheimer's and other forms of dementia. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Ann Robinson Tags: Analysis Source Type: research

More clarity needed on the true benefits and risks of statins
The benefits and risks of statins have recently been the subject of much controversy and debate. Dr Malhotra and colleagues argue that selective reporting and publication bias may be overestimating the efficacy and underestimating the side‐effects of statins. (Source: Prescriber)
Source: Prescriber - December 15, 2016 Category: Primary Care Authors: Aseem Malhotra, John Abramson, Michel De Lorgeril, Sherif Sultan Tags: Opinion Source Type: research

Enstilar cutaneous foam for the treatment of psoriasis vulgaris
This article discusses its place in therapy, efficacy and adverse effects. (Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Authors: Steve Chaplin Tags: New Products Source Type: research

Optimising care for people with motor neurone disease
The prospects for patients with a diagnosis of motor neurone disease are bleak; the disease progresses rapidly, life expectancy is low and there is currently no cure. However, recent initiatives are helping to improve patients' quality of life through earlier diagnosis and optimising care. (Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Authors: Danny Buckland Tags: Research Source Type: research

Treatment of polycystic ovarian syndrome in primary care
This article reviews the recommended management of PCOS and its associated symptoms in primary care and discusses when referral is necessary. (Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Authors: Anna Graham, Haitham Hamoda Tags: Drug Review Source Type: research

Sacubitril/valsartan for chronic heart failure: its future potential
Sacubitril/valsartan (Entresto), a combined neprilysin inhibitor/angiotensin II‐receptor antagonist for the treatment of chronic heart failure with reduced ejection fraction, was launched in the UK in January. The phase 3 clinical trial PARADIGM‐HF established its efficacy in chronic heart failure but what is its future place in therapy, according to the latest guidelines and research? (Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Authors: Steve Chaplin Tags: Therapy Review Source Type: research

New from Nice
(Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Tags: New from Nice Source Type: research

Recent advances in the management of cystic fibrosis
This article examines the expanding role of primary care in the management of cystic fibrosis and discusses the availability of new treatments that target the underlying cause of the disease. (Source: Prescriber)
Source: Prescriber - December 12, 2016 Category: Primary Care Authors: Danny Buckland Tags: Report Source Type: research